Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Rasmussen

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Clinical Biochemistry|June 7, 2020
Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancerLine J H Rasmussen, Martin Schultz, Kasper Iversen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 21, 2020
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPDKjell E J Håkansson, Charlotte S Ulrik, Nina S Godtfredsen, et al.
Psychoneuroendocrinology|March 1, 2023
Systematic review and meta-analysis of the effect of adverse childhood experiences (ACEs) on brain-derived neurotrophic factor (BDNF) levelsNeha Vyas, Courtney E Wimberly, M Makenzie Beaman, et al.
Respiratory Research|November 16, 2019
The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort studyK E J Håkansson, Line J H Rasmussen, Nina S Godtfredsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2020
Adolescents' perceptions of family social status correlate with health and life chances: A twin difference longitudinal cohort studyJoshua Rivenbark, Louise Arseneault, Avshalom Caspi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinomaJ H Rasmussen, C Grønhøj, K Håkansson, et al.
Brain, Behavior, and Immunity|January 6, 2022
Longitudinal associations between adolescents' individualised risk for depression and inflammation in a UK cohort studyRachel M Latham, Christian Kieling, Louise Arseneault, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 13, 2019
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trialMartin Schultz, Line J H Rasmussen, Thomas Kallemose, et al.
HIV Medicine|September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control studyL J H Rasmussen, A Knudsen, T L Katzenstein, et al.
The British Journal of Radiology|January 31, 2015
Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MRJ H Rasmussen, B M Fischer, M C Aznar, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Clinical Biochemistry|June 7, 2020
Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancerLine J H Rasmussen, Martin Schultz, Kasper Iversen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 21, 2020
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPDKjell E J Håkansson, Charlotte S Ulrik, Nina S Godtfredsen, et al.
Psychoneuroendocrinology|March 1, 2023
Systematic review and meta-analysis of the effect of adverse childhood experiences (ACEs) on brain-derived neurotrophic factor (BDNF) levelsNeha Vyas, Courtney E Wimberly, M Makenzie Beaman, et al.
Respiratory Research|November 16, 2019
The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort studyK E J Håkansson, Line J H Rasmussen, Nina S Godtfredsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2020
Adolescents' perceptions of family social status correlate with health and life chances: A twin difference longitudinal cohort studyJoshua Rivenbark, Louise Arseneault, Avshalom Caspi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinomaJ H Rasmussen, C Grønhøj, K Håkansson, et al.
Brain, Behavior, and Immunity|January 6, 2022
Longitudinal associations between adolescents' individualised risk for depression and inflammation in a UK cohort studyRachel M Latham, Christian Kieling, Louise Arseneault, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 13, 2019
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trialMartin Schultz, Line J H Rasmussen, Thomas Kallemose, et al.
HIV Medicine|September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control studyL J H Rasmussen, A Knudsen, T L Katzenstein, et al.
The British Journal of Radiology|January 31, 2015
Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MRJ H Rasmussen, B M Fischer, M C Aznar, et al.
Pageof 5